Production of antisera to phenylbutazone and oxyphenylbutazone for use in immunochemical detection assays

References

• Arifah, A. K., & Lees, P. (2002). Pharmacodynamics and pharmacokinetics of phenylbutazone in calves. Journal of Veterinary Pharmacology and Therapeutics, 25, 299–309. doi: 10.1046/j.1365-2885.2002.00421.x
   PubMed Web of Science ®Google Scholar
• CRL Guidance paper. (2007). CRLs view on state of the art analytical methods for national residue control plans. Retrieved from: http://www.bvl.bund.de/SharedDocs/Downloads/09_Untersuchungen/EURL_Empfehlungen_Konzentrationsauswahl_Methodenvalierungen.pdf__blob=publicationFile.
   Google Scholar
• De Veau, E. J. I. (1999). Determination of non-protein bound phenylbutazone in bovine plasma using ultrafiltration and liquid chromatography with ultraviolet detection. Journal of Chromatography B: Biomedical Sciences and Applications, 721, 141–145. doi: 10.1016/S0378-4347(98)00487-3
   PubMed Web of Science ®Google Scholar
• De Veau, E. J. I., Pedersoli, W., Cullison, R., & Baker, J. (1998). Pharmacokinetics of phenylbutazone in plasma and milk of lactating dairy cows. Journal of Veterinary Pharmacology and Therapeutics, 21, 437–443. doi: 10.1046/j.1365-2885.1998.00167.x
   PubMed Web of Science ®Google Scholar
• Dowling, G., Gallo, P., Malone, E., & Regan, L. (2009). Rapid confirmatory analysis of non-steroidal anti-inflammatory drugs in bovine milk by rapid resolution liquid chromatography tandem mass spectrometry. Journal of Chromatography A, 1216, 8117–8131. doi: 10.1016/j.chroma.2009.05.004
   PubMed Web of Science ®Google Scholar
• European Food Safety Authority. (2014). Report for 2012 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. EFSA supporting publication 2014: EN-540.
   Google Scholar
• European Food Safety Authority and European Medicines Agency. (2013). Joint statement of EFSA and EMA on the presence of residues of phenylbutazone in horse meat. EFSA Journal, 11, Article no. 3190, 1–45.
   Google Scholar
• European Medicines Agency. (1997). Committee for Medicinal Products for Veterinary Use: Phenylbutazone. Summary Report, EMEA/MRL/297/97-FINAL October 1997.
   Google Scholar
• Fodey, T. L., George, S. E., Traynor, I. M., Delahaut, P., Kennedy, D. G., Elliott, C. T., & Crooks, S. R. H. (2013). Approaches for the simultaneous detection of thiamphenicol, florfenicol and florfenicol amine using immunochemical techniques. Journal of Immunological Methods, 393, 30–37. doi: 10.1016/j.jim.2013.04.003
   PubMed Web of Science ®Google Scholar
• Haque, A., & Stewart, J. T. (1997). Direct injection HPLC method for the determination of phenylbutazone and oxyphenylbutazone in serum using a semipermeable surface column. Journal of Pharmaceutical and Biomedical Analysis, 16, 287–293. doi: 10.1016/S0731-7085(97)00041-1
   PubMed Web of Science ®Google Scholar
• Igualada, C., & Moragues, F. (2005). Determination of phenylbutazone and oxyphenbutazone in animal urine by ion trap liquid chromatography–mass spectrometry. Analytica Chimica Acta, 529, 235–238. doi: 10.1016/j.aca.2004.10.034
   Web of Science ®Google Scholar
• Jaraiz, M. V., Rodriguez, C., San Andres, M. D., Gonzalez, F., & San Andres, M. I. (1999). Disposition and tolerance of suxibuzone in horses. Equine Veterinary Journal, 31, 411–416. doi: 10.1111/j.2042-3306.1999.tb03841.x
   PubMed Web of Science ®Google Scholar
• Jedziniak, P., Szprengier-Juszkiewicz, T., Olejnik, M., & Zmudzki, J. (2010). Determination of non-steroidal anti-inflammatory drugs residues in animal muscles by liquid chromatography–tandem mass spectrometry. Analytica Chimica Acta, 672, 85–92. doi: 10.1016/j.aca.2010.04.031
   PubMed Web of Science ®Google Scholar
• Kawashima, K., Dixon, R., & Spector, S. (1975). Development of radioimmunoassay for chlorpromazine. European Journal of Pharmacology, 32, 195–202. doi: 10.1016/0014-2999(75)90283-6
   PubMed Web of Science ®Google Scholar
• Kwiatkowski, S., Goodman, J.P., Stanley, S.D., Tai, C.L., Yang, J.-M., Wood, T., … Tobin, T. (1989). Immunoassay detection of drugs in racing horses X. Detection of phenylbutazone in equine blood and urine by particle concentration fluoroimmunoassay and ELISA. Research Communications in Substances of Abuse, 10, 123–139.
   Google Scholar
• Lees, P., Ayliffe, T., Maitho, T. E., & Taylor, J. B. O. (1988). Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral-administration. Research in Veterinary Science, 44, 57–67.
   PubMed Web of Science ®Google Scholar
• Lees, P., & Toutain, P. L. (2013a). Pharmacokinetics, pharmacodynamics, metabolism, toxicology and residues of phenylbutazone in humans and horses. Veterinary Journal, 196, 294–303. doi: 10.1016/j.tvjl.2013.04.019
   PubMed Web of Science ®Google Scholar
• Lees, P., & Toutain, P. L. (2013b). Phenylbutazone in horses and man: Properties relevant to safety of humans consuming horse meat containing phenylbutazone and its metabolites. Equine Veterinary Education, 25, 545–549. doi: 10.1111/eve.12112
   Web of Science ®Google Scholar
• Meucci, V., Vanni, M., Sgorbini, M., Odore, R., Minunni, M., & Intorre, L. (2013). Determination of phenylbutazone and flunixin meglumine in equine plasma by electrochemical-based sensing coupled to selective extraction with molecularly imprinted polymers. Sensors and Actuators B: Chemical, 179, 226–231. doi: 10.1016/j.snb.2012.09.015
   Web of Science ®Google Scholar
• Mizushima, Y., Shiokawa, Y., Honma, M., & Kageyama, T. (1983). A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid-arthritis. International Journal of Tissue Reactions – Experimental and Clinical Aspects, 5, 35–39.
   PubMedGoogle Scholar
• Monreal, L., Sabate, D., Segura, D., Mayos, I., & Homedes, J. (2004). Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses. Research in Veterinary Science, 76, 145–149. doi: 10.1016/j.rvsc.2003.10.004
   PubMed Web of Science ®Google Scholar
• Neto, L. M. R., Andraus, M. H., & Salvadori, M. C. (1996). Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography–mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications, 678, 211–218. doi: 10.1016/0378-4347(95)00508-0
   PubMed Web of Science ®Google Scholar
• O'Mahony, P. J. (2013). Finding horse meat in beef products – A global problem. Qjm – An International Journal of Medicine, 106, 595–597. doi: 10.1093/qjmed/hct087
   PubMed Web of Science ®Google Scholar
• Taylor, M. R., & Westwood, S. A. (1995). Quantitation of phenylbutazone and oxyphenbutazone in equine plasma by high-performance liquid-chromatography with solid-phase extraction. Journal of Chromatography A, 697, 389–396. doi: 10.1016/0021-9673(94)00834-V
   Web of Science ®Google Scholar
• Thompson, T. S., Noot, D. K., & Kendall, J. D. (2010). Surveillance study of novobiocin and phenylbutazone residues in raw bovine milk using liquid chromatography–tandem mass spectrometry. Food Additives and Contaminants Part a – Chemistry Analysis Control Exposure & Risk Assessment, 27, 1104–1111.
   Web of Science ®Google Scholar
• Tobin, T., Chay, S., Kamerling, S., Woods, W. E., Weckman, T. J., Blake, J. W., & Lees, P. (1986). Phenylbutazone in the horse – A review. Journal of Veterinary Pharmacology and Therapeutics, 9, 1–25. doi: 10.1111/j.1365-2885.1986.tb00008.x
   PubMed Web of Science ®Google Scholar
• Van Hoof, N., De Wasch, K., Poelmans, S., Noppe, H., & De Brabander, H. (2004). Multi-residue liquid chromatography/tandem mass spectrometry method for the detection of non-steroidal anti-inflammatory drugs in bovine muscle: Optimisation of ion trap parameters. Rapid Communications in Mass Spectrometry, 18, 2823–2829. doi: 10.1002/rcm.1683
   PubMed Web of Science ®Google Scholar
• Yasuda, Y., Shindo, T., Mitani, N., Ishida, N., Oono, F., & Kageyama, T. (1982). Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans. Journal of Pharmaceutical Sciences, 71, 565–572. doi: 10.1002/jps.2600710521
   PubMed Web of Science ®Google Scholar